Greco-Roman wrestler Deepak was withdrawn from India's 2026 Asian Games squad on September 9, 2026, after his trial sample returned an adverse finding for clomifene. Handled by the Wrestling Federation of India, the exclusion marks the third doping setback for the national contingent, reducing India's wrestling participation options.
Backed by official anti-doping notifications, Greco-Roman wrestler Deepak has been withdrawn from India's 2026 Asian Games delegation following an adverse analytical finding.
Delivering a severe blow to India’s combat sports campaign ahead of the upcoming international showcase, Greco-Roman wrestler Deepak has been officially removed from the Asian Games squad. Announced on Wednesday, September 9, 2026, the decision by the Wrestling Federation of India (WFI) follows a notification from the National Anti-Doping Agency (NADA) indicating that Deepak’s urine sample—collected during national selection trials at the Sports Authority of India (SAI) Regional Centre in Lucknow on May 31—returned an adverse finding for clomifene.
The developing situation marks the third pre-tournament doping casualty for the Indian wrestling contingent, intensifying scrutiny over athlete monitoring and testing timelines.
Evaluating Doping Violations, Testing Timelines, and Contingent Impact
Analyzing the regulatory sequence reveals significant friction between sample collection dates and administrative notification procedures. According to official disclosures released on September 9, 2026, core operational highlights include:
Prohibited Substance Detection: NADA identified clomifene—classified under S4 Hormone and Metabolic Modulators on the World Anti-Doping Agency (WADA) Prohibited List—following investigations that progressed from an atypical finding reported on July 23.
WFI Preemptive Action: Although formal final disciplinary proceedings are ongoing and the athlete retains the right to request a B-sample analysis within seven days, the WFI chose to withdraw Deepak to avoid potential international governing body (UWW) fines reaching up to Rs 20 lakh should a retest fail during the Games.
Broader Contender Attrition: Deepak’s exclusion follows earlier doping violations involving freestyle 86kg wrestler Mukul Dahiya and Greco-Roman 130kg competitor Deepanshu, shrinking India's overall competitive entries.
Administrative Concerns: WFI representatives expressed frustration over delayed testing turnarounds, noting that earlier notifications would have allowed the federation to field replacement athletes in the affected weight categories.
Why It Matters
The practical implications of pre-tournament doping disqualifications severely compromise national medal tallies and disrupt long-term training preparations. For athletes and coaches, delayed testing results prevent timely substitutions, leaving key weight classes completely unrepresented at major international fixtures. For sports administrators, the recurring violations underscore an urgent need to tighten internal compliance and educational frameworks across all training camps.
Key Facts at a Glance
Affected Athlete: Greco-Roman wrestler Deepak (67kg category).
Prohibited Substance: Clomifene (S4 Hormone and Metabolic Modulators).
Governing Body Action: Withdrawn from the 2026 Asian Games squad by the Wrestling Federation of India.
Broader Impact: Third wrestling doping case following Mukul Dahiya and Deepanshu, reducing India's overall squad depth.
FAQ Section
Why was Greco-Roman wrestler Deepak removed from the Asian Games squad?
Deepak was withdrawn after his selection trial sample returned an adverse analytical finding for clomifene, a prohibited metabolic modulator.
What is clomifene and why is it banned?
Clomifene is a prescription medication primarily used to treat infertility. It is banned under the WADA Prohibited List (S4 category) because it can function as an estrogen modulator and potential masking agent.
How many wrestlers have been affected by doping cases ahead of the Games?
Deepak is the third wrestler—following Mukul Dahiya and Deepanshu—to be impacted by pre-tournament doping violations.
Can Deepak contest the current adverse finding?
Yes, Deepak has the right to challenge the initial finding by requesting an analysis of his B-sample within seven days of receiving the notification.
Where can readers find official updates on anti-doping rulings?
Verified investigation updates and regulatory notices are published through National Anti-Doping Agency (NADA) and sports news desks like Outlook India.
Source: Outlook India Sports Desk, India Today Sports, The New Indian Express, Jansatta